Navigation Links
EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
Date:10/24/2007

ertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

CONTACT:

Ginny Dunn

Associate Director, Corporate Communications & Investor Relations

EntreMed, Inc.

240.864.2643


'/>"/>
SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Experimental treatment for Ebola Virus Shows promising results in mice
8. Hormone Deficiency Results In Miscarriage
9. Gleevec gets hopeful results
10. Breast Implants May Interfere With The Interpretation Of Mammogram Results
11. DNA Testing For More Accurate Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
(Date:12/4/2009)Dr. Redlener Applauds Historic Effort but Points out Potential Risk if America,s Safety Net Programs Are Lost in Final Health Care Reform ,, NEW YORK, Dec. 4 The New England Journal of Medicine
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2
...nn., Oct. 5 Emdeon Business Services,announced to...yers for,insurance eligibility and benefits verifi...ugh its vendor partners and through the Emdeon sui...ers,dental practices nationwide real-time eligibil...
... Mich., Oct. 5 Volkswagen of America,Inc., in con...na Volkswagen,dealers, proudly announces its 12th ...k Chicago Marathon. "We,re delighted to continue ...y for Volkswagen, our dealer,partners, our custome...
...N.C., Oct. 5 While Megabrands are more and,more a...cialty therapeutic,areas, the underlying principle...ckbuster drug that will outperform the competition...aunching,Pharmaceutical Megabrands: Best Practices...
...ree Action Camera to Capture Exclusive Event Foota...e of the,world,s leading designers and marketers o...y announced a partnership with the Love Hope,Stren...erest Rocks will culminate with the first-ever roc...
...N, Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life S...ogy-driven Canadian,biopharmaceutical company, tod...e U.S. Department of Agriculture (USDA) regarding ...tatistical,treatment of results from the field use...
...rp. is the distributor of the popular dietary supp...M), MELBOURNE, Fla., Oct. 5 New Health Corp. is ... again and LipidShield Plus(TM) is,now available a...en to lower cholesterol and,triglycerides while im...
Other Medicine News:Health News:Emdeon Business Services Extends Market Leadership With New Dental Eligibility Payers 2Health News:Volkswagen Continues Sponsorship of the Lasalle Bank Chicago Marathon 2Health News:Pharmaceutical Product Marketing: Launching Drugs That Outperform the Competition 2Health News:Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest 2Health News:Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest 3Health News:Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine 2Health News:Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine 3Health News:New Health Corp. Announces the Addition of Stop & Shop and Giant Supermarkets to its Retail Outlets 2
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 1Visage Imaging Introduces Visage 28R 29 7 for Windows and Mac OS X 6500 2Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 1Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 2Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 3FOX Thanksgiving Day Special Kaleidoscope Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 6496 1FOX Thanksgiving Day Special Kaleidoscope Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 6496 2FOX Thanksgiving Day Special Kaleidoscope Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 6496 3
Disposable Filter-Tips, 1100 l (960)
300 L Filter Barrier Pipette Tip
ART 250E
...otic Certified Tips for its full line of 96- and 3...he highest quality, PerkinElmer Robotic Certified ...led accuracy in high throughput applications. Tips...ume range from 0.5 L to 235 L. Tips for 384-channe...
Medicine Products: